ONCOCYTE CORPORATION's ticker is and the CUSIP is 68235C957. A total of 2 filers reported holding ONCOCYTE CORPORATION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 300 | -40.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -97.6% | 500 | -93.2% | 0.00% | – |
| Q2 2021 | $42,000 | -2.3% | 7,400 | -9.8% | 0.00% | – |
| Q1 2021 | $43,000 | +72.0% | 8,200 | -21.2% | 0.00% | – |
| Q4 2020 | $25,000 | +525.0% | 10,400 | +420.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $0 | 0.00% |